A diversified portfolio of products for high-potential markets
BECAUSE RESULTS MATTER
Therapy-07
PRESCRIPTION
This triple combination therapy works synergistically to encourage optimal hair regrowth in men with androgenic alopecia. Significant regrowth was observed among participants in the clinical trials.
Find out more on how to get it in the US or in Canada. For other countries, please sign up for the waiting list and we will keep you informed.
Therapy-16
OVER-THE-COUNTER NATURAL PRODUCT
This clinically proven natural formula beats market-leading synthetic formulas and is the perfect choice for men and women looking to prevent hair loss and boost hair growth and thickness.
Therapy-16 is now available as:
- RIZN’s Density Spray for men
- Plenty Natural’s Densifying Spray for women
Some market
numbers
40 years
First drug approved for androgenic alopecia in 40 years.
$2,560
Average spent for hair loss products in the US per patient, per year.
$8.77 B
Hair loss is a US$8.77 billion industry in 2024.
98%
Rogaine and versions of private label Minoxidil control 98% of the topical hair growth market in the U.S.
$16.4 B
Global projected market in 2030.
Recent publications
Array
(
[posts_per_page] => 3
[post_type] => post
[post_status] => publish
)
SUBSCRIBE TO OUR MAILING LIST